What Sparked Quince Therapeutics (QNCX) Stock To Rise 53% After Hours

Benzinga_recent_news02-13

Quince Therapeutics Inc. (NASDAQ:QNCX) shares increased 52.99% in the after-hours session to $0.34 on Thursday. According to Benzinga Pro data, the stock of the California-based biotech closed regular...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2611026138?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/13/Financial-Graph-With-Uptrend-Line-Techno.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-02-13 14:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2611026138","market":"us","top_or_hot":-1,"title":"What Sparked Quince Therapeutics (QNCX) Stock To Rise 53% After Hours","media":"Benzinga_recent_news","content":"<div>\n<p>Quince Therapeutics Inc. (NASDAQ:QNCX) shares increased 52.99% in the after-hours session to $0.34 on Thursday.\nAccording to Benzinga Pro data, the stock of the California-based biotech closed regular...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/26/02/50602390/what-sparked-quince-therapeutics-qncx-stock-to-rise-53-after-hours\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Sparked Quince Therapeutics (QNCX) Stock To Rise 53% After Hours</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Sparked Quince Therapeutics (QNCX) Stock To Rise 53% After Hours\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-13 14:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/equities/26/02/50602390/what-sparked-quince-therapeutics-qncx-stock-to-rise-53-after-hours><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Quince Therapeutics Inc. (NASDAQ:QNCX) shares increased 52.99% in the after-hours session to $0.34 on Thursday.\nAccording to Benzinga Pro data, the stock of the California-based biotech closed regular...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/26/02/50602390/what-sparked-quince-therapeutics-qncx-stock-to-rise-53-after-hours\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.benzinga.com/markets/equities/26/02/50602390/what-sparked-quince-therapeutics-qncx-stock-to-rise-53-after-hours","article_id":"2611026138","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/13/Financial-Graph-With-Uptrend-Line-Techno.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/02/50602390/what-sparked-quince-therapeutics-qncx-stock-to-rise-53-after-hours","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2611026138","pubTimestamp":1770965460,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Quince Therapeutics shares surged 53% after hours Thursday following the engagement of LifeSci Capital as financial advisor amid restructuring and strategic plans.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4150":"赌场与赌博","QNCX":"Quince Therapeutics, Inc.","RSI":"Rush Street Interactive, Inc."},"translate_title":"是什么促使Quince Therapeutics(QNCX)股价盘后上涨53%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RSI":1,"QNCX":1.5},"content_text":"Quince Therapeutics Inc. (NASDAQ:QNCX) shares increased 52.99% in the after-hours session to $0.34 on Thursday.\nAccording to Benzinga Pro data, the stock of the California-based biotech closed regular trading down 63.03% at $0.23.\nQuince Therapeutics filed a Securities and Exchange Commission filing on Thursday, disclosing that it engaged New York-based LifeSci Capital on Monday as its exclusive financial advisor to assist with restructuring activities and evaluate strategic alternatives, including a reverse merger.\nThe company also reported that the NEAT clinical trial, a Phase 3, randomized, double-blind, placebo-controlled study for its lead drug candidate eDSP, did not meet its primary or secondary endpoints.\nAs of Dec. 31, 2025, Quince Therapeutics had about $5.8 million in cash, $11.9 million in short-term investments and $16.4 million outstanding on its unsecured European Investment Bank line of credit, according to preliminary unaudited estimates.\nThe filing states that since Jan. 29, the closing price of the company’s common stock on the Nasdaq Global Select Market has been less than $1.00 clouding delisting fears.\nQuince Therapeutics has a Relative Strength Index (RSI) of 28.57.\nThe market capitalization of the late-stage biotechnology company stands at $12.56 million, with its shares reaching a 52-week high of $4.55 and a low of $0.13.\nOver the past 12 months, the stock has fallen 84.12%.\nCurrently, the stock is positioned at approximately 2.3% of its 52-week range, near the low end.\nQNCX’s steep drop and weak position indicate that any potential recovery would require clear confirmation before investors consider taking significant action.\nBenzinga's Edge Stock Rankings indicate that QNCX has a negative price trend across all time frames.\nPhoto Courtesy: Champ008 on Shutterstock.com\nDisclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.\nTo add Benzinga News as your preferred source on Google, click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2611026138","isCrawlerRequest":true}